The Use of Cell Therapies for Autoimmune Diseases: CAR-T

The Use of Cell Therapies for Autoimmune Diseases: CAR-T

Program Directors: Dominique Farge, Fermin Sanchez-Guijo, Bruce Levine

Planning Faculty: Raffaella Greco, Andreas Mackensen, George Schett

This leading-edge ISCT training course is a 1.5-day CME accredited event dedicated to the translation of CAR-T therapies for auto-immune diseases, from basic research to clinical practice. It is designed for approximately 150 clinicians, clinical scientists, medical students, and researchers, including seasoned professionals from top-tier academic institutions and directors from R&D cell therapy units and the regulatory sector.

The meeting will be led by pioneering experts in the development of CAR-T cell therapies for autoimmune diseases. Together, the faculty and registered participants will explore targeted biological therapies and address the challenges and solutions related to CAR-T cell treatments in these conditions. The meeting will offer unique opportunities for face-to-face interaction with global experts in the field.

Regulatory requirements and manufacturing processes will be discussed during the program. Real-world case studies and clinical success stories will be shared. Insight into recent clinical progress will be provided. Attendees will also gain an understanding of current registries, reports, and data analysis relevant to the clinical applications of CAR-T cells in auto-immune diseases.

Register Now

Secure your spot in this course to gain valuable insights and expertise in CAR-T cell therapy.

View Course Outline

Click here to download the course outline

Contact Us

In-person
1.5-day training
October 16–17, 2025

Hosted in:

Verniquet Amphitheatre
Muséum national d'Histoire naturelle
57 rue Cuvier, 75005 Paris, France

WHAT YOU WILL LEARN

  • Insights from global experts on advancements and future prospects of CAR-T cell therapy for autoimmune diseases
  • The principles of clinical trial study design, including observations and outcomes related to CAR-T cell applications in auto-immune conditions
  • Strategies for translating research findings into clinical CAR-T cell manufacturing
  • Approaches to generating reliable evidence that informs clinical decision-making and supports regulatory submission
  • The financial model for developing and commercializing CGT products

PRICE (USD)

Training Course Only IISCT Members INon-Members (registration include 1 year ISCT e-membership, which will be issued post event)
Student $195 $260
Resident / Fellow / Postdoc $195 $270
Technologist / Pharmacist / Nurse Practitioner / Nurse $295 $440
Academic $295 $495
Industry $385 $570
 15% Group Registration Discount available for 5+ Members / Non-Members from the same institution

Group Registration Discount:

  • Receive 15% off when registering 5+ ISCT Members / Non-Members from the same company / institution.

  • Contact ISCT at workforcedevelopment@isctglobal.org to obtain the discounted Group Registration Rate.

DESIGNED FOR:

Clinical researchers, clinicians, and physicians involved in CAR-T cell translation for clinical applications.

ACCREDITED BY:

The course offers 10 Hours of Continuing Education (EBAH-CME) and CMLE Credits.

UPON COMPLETION, YOU WILL RECEIVE:
  • Certificate of Course Completion from ISCT

Note: Completing all training modules and passing the quizzes is mandatory to receive a course completion certificate. 

THANK YOU TO OUR SPONSOR

COURSE DIRECTORS

 PLANNING FACULTY 

 SPEAKERS 

YOU MAY ALSO BE INTERESTED IN:

The Use of Cell Therapies for Autoimmune Diseases: MSC

Format: Self-paced virtual course
Length: 8 hours of comprehensive content

Developed by principal investigators behind landmark MSC research and clinical studies, this on-demand course provides advanced knowledge and critical insights on the use of MSC for autoimmune diseases.